Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

645 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancers.
Hagio K, Kikuchi J, Takada K, Tanabe H, Sugiyama M, Ohhara Y, Amano T, Yuki S, Komatsu Y, Osawa T, Hatanaka KC, Hatanaka Y, Mitamura T, Yabe I, Matsuno Y, Manabe A, Sakurai A, Ishiguro A, Takahashi M, Yokouchi H, Naruse H, Mizukami Y, Dosaka-Akita H, Kinoshita I. Hagio K, et al. Among authors: hatanaka kc, hatanaka y. Cancer Sci. 2023 Aug;114(8):3385-3395. doi: 10.1111/cas.15837. Epub 2023 May 19. Cancer Sci. 2023. PMID: 37208840 Free PMC article.
Guidelines for Handling of Cytological Specimens in Cancer Genomic Medicine.
Morii E, Hatanaka Y, Motoi N, Kawahara A, Hamakawa S, Kuwata T, Nagatomo T, Oda Y, Okamoto A, Tanaka R, Iyoda A, Ichiro M, Matsuo Y, Nakamura N, Nakai T, Fukuhara M, Tokita K, Yamaguchi T, Takenaka M, Kawabata A, Hatanaka KC, Tsubame K, Satoh Y; Working Group on Cytology in the Era of Genomic Medicine. Morii E, et al. Among authors: hatanaka kc, hatanaka y. Pathobiology. 2023;90(5):289-311. doi: 10.1159/000528346. Epub 2023 Feb 8. Pathobiology. 2023. PMID: 36754025 Free PMC article. Review.
Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region.
Tomioka N, Hatanaka KC, Okuyama D, Watanabe KI, Yamamoto M, Maeda H, Tachikawa H, Kuwahara S, Shimizu A, Suzuki H, Hatanaka Y, Takahashi M. Tomioka N, et al. Among authors: hatanaka kc, hatanaka y. Breast Cancer. 2023 May;30(3):497-505. doi: 10.1007/s12282-023-01442-9. Epub 2023 Mar 9. Breast Cancer. 2023. PMID: 36892732 Free PMC article.
Correction: Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region.
Tomioka N, Hatanaka KC, Okuyama D, Watanabe KI, Yamamoto M, Maeda H, Tachikawa H, Kuwahara S, Shimizu A, Suzuki H, Hatanaka Y, Takahashi M. Tomioka N, et al. Among authors: hatanaka kc, hatanaka y. Breast Cancer. 2023 Jul;30(4):689-690. doi: 10.1007/s12282-023-01454-5. Breast Cancer. 2023. PMID: 37103743 Free PMC article. No abstract available.
Deep fibrous histiocytoma of the index finger: a case report.
Shibayama H, Matsui Y, Kawamura D, Momma D, Endo T, Matsui Y, Yawaka Y, Hatanaka KC, Takakuwa E, Sugino H, Hatanaka Y, Hasegawa T, Iwasaki N. Shibayama H, et al. Among authors: hatanaka kc, hatanaka y. Case Reports Plast Surg Hand Surg. 2023 May 5;10(1):2207637. doi: 10.1080/23320885.2023.2207637. eCollection 2023. Case Reports Plast Surg Hand Surg. 2023. PMID: 37168675 Free PMC article.
Clinical practice guidelines for molecular tumor markers, 2nd edition review part 1.
Kikuchi Y, Shimada H, Hatanaka Y, Kinoshita I, Ikarashi D, Nakatsura T, Kitano S, Naito Y, Tanaka T, Yamashita K, Oshima Y, Nanami T. Kikuchi Y, et al. Among authors: hatanaka y. Int J Clin Oncol. 2024 Jan;29(1):1-19. doi: 10.1007/s10147-023-02430-x. Epub 2023 Nov 29. Int J Clin Oncol. 2024. PMID: 38019341
645 results